Delivery Order SPE2DB22D3501-SPE2DB24FVG49
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,102.17 and a period of performance through February 20, 2024. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $10,919.53 and a period of performance through March 26, 2024, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for GEMTESA 75 MG TABLET 90S, with a firm fixed price of $5,869.79 and a completion date of June 7, 2024. The IDC held by AmerisourceBergen with DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.87, is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through June 28, 2024 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,376.00, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a $11,196.94 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of March 19, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,281.24 firm fixed price contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The delivery order, valued at $10,346.40, is for the supply of the medication GEMTESA 75 MG TABLET 30S to support military treatment programs and facilities. The contract has an ultimate completion date of April 10, 2024 and does not have a set-aside...
- This is a Delivery Order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the medical supply item "GEMTESA 75 MG TABLET 30S" and has a ceiling value of $1,164.10. The contract is Firm Fixed Price and has an ultimate completion date of July 10, 2024. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract is a firm fixed-price delivery order with a ceiling value of $2,013.21 and a period of performance through July 2, 2025. It is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVG49Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $5,941.88, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for AmerisourceBergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation has been used for this contract or the larger IDC. This delivery order has an ultimate completion date of April 15, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 4/12/24 |